Free Trial
NASDAQ:ESLAW

Estrella Immunopharma (ESLAW) Stock Price, News & Analysis

$0.09 +0.00 (+3.61%)
(As of 12/20/2024 05:16 PM ET)

About Estrella Immunopharma Stock (NASDAQ:ESLAW)

Key Stats

Today's Range
$0.09
$0.09
50-Day Range
$0.04
$0.12
52-Week Range
$0.03
$0.19
Volume
1,049 shs
Average Volume
5,095 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.

Receive ESLAW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter.

ESLAW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

ESLAW Stock Analysis - Frequently Asked Questions

Estrella Immunopharma's stock was trading at $0.03 on January 1st, 2024. Since then, ESLAW shares have increased by 206.3% and is now trading at $0.0919.
View the best growth stocks for 2024 here
.

Shares of ESLAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:ESLAW
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

This page (NASDAQ:ESLAW) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners